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Domenico A Coviello7, Lina Florentin8, Hans Scheffer9 and Martina Rincic10 on behalf of the Clinical
Laboratory Geneticists Professional Branch Board, European Board of Medical Genetics, Vienna, Austria
Tremendous progress in genetics and genomics led to a wide range of healthcare providers, genetic tests, and more patients who
can benefit from these developments. To guarantee and improve the quality of genetic testing, a unified European-based
registration for individuals qualified in biomedicine was realized. Therefore a Europe-wide recognition of the profession ‘European
registered Clinical Laboratory Geneticist (ErCLG)’ based on a syllabus of core competences was established which allows for
harmonization in professional education. The ‘European Board of Medical Genetics division − Clinical Laboratory Geneticist’
provides now since 3 years the possibility to register as an ErCLG. Applicants may be from all European countries and since this
year also from outside of Europe. Five subtitles reflect the exact specialty of each ErCLG, who can reregister every 5 years. A
previously not possible statistics based on ~300 individuals from 19 countries as holders of an ErCLG title provides interesting
insights into the professionals working in human genetics. It could be substantiated that there are around twice as many females
than males and that a PhD title was achieved by 80% of registered ErCLGs. Also most ErCLGs are still trained as generalists
(66%), followed by such ErCLGs with focus on molecular genetics (23%); the remaining are concentrated either on clinical
(6%), tumor (4%) or biochemical genetics (1%). In conclusion, besides MDs and genetic counselors/nurses an EU-wide
recognition system for Clinical Laboratory Geneticist has been established, which strengthens the status of specialists working in
human genetic diagnostics in Europe and worldwide.
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INTRODUCTION
Technological advances in genetics and genomics have resulted in
genetic testing being used by a wide range of healthcare providers.
Multiple genetic tests are now available, increasing numbers of patients
can benefit from genetic testing and genetic testing is now more
publicly affordable (in both public and private laboratories).1 This
situation brings benefits as well as problems, as concerns about the
quality of diagnostic tests offered by non-genetic specialists have been
raised for at least 10 years.1–4 The European Society of Human
Genetics (ESHG) was one of those who discussed early how to
encounter the differences among the different countries in Europe
concerning provision of genetic services. ESHG and its Public and
Professional Policy Committee examined the professional and scien-
tific views on the social, ethical and legal issues that influence genetic
services throughout member states of European Union.5 One of the
most important key elements in improving the quality of genetic
testing in Europe was the provision of appropriate genetic education
for health professionals. The work carried out by EuroGentest-
Network of Excellence6 underlined the need for concerted efforts to
provide professional education to a range of health professionals who
play a role in providing genetic testing.7 Patient information was also
considered as one of the milestones to provide an appropriate genetic
counseling.8 Moreover, thanks to the work carried out by
the Education Committee of the ESHG, the core competences to
support preparation of health professionals in Europe were published
in 2010.9
Thus, in order to potentiate the best possible healthcare and to
ensure appropriate levels of competence, there is a proven need for
establishing a unified European-based registration for individuals
qualified in biomedicine who work in a human genetics diagnostic
laboratory, that is, biology and related subjects. These professionals
are mainly trained as scientists but then they were appointed in a
genetic diagnostic setting. In parallel also some medical doctors
decided to work full time in laboratory settings and they are also
involved. Therefore a Europe-wide recognition of the profession
‘European registered Clinical Laboratory Geneticist (ErCLG)’ based
on a syllabus of core competences (https://www.eshg.org/fileadmin/
eshg/EBMG/CLG/Core-Curriculum_2016.pdf) will allow harmoni-
zation in professional education. Similar efforts were already
undertaken for genetic counselors;10 MDs working in genetic
counseling are already recognized by EU-laws (https://www.eshg.
org/111.0.html).
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BACKGROUND
An increasing need for recognition of a laboratory specialty in human
genetic diagnostics was recognized by the ESHG in 2010/2011. Thus, an
‘Ad hoc core committee: laboratory genetics’ was then brought into
being (Jacqueline Schoumans (chair), Egbert Bakker (co-chair), et al.).
After establishing the European Board of Medical Genetics (EBMG) in
June 2012 (legal entity since June 2014) the ‘European Board of Medical
Genetics division – Clinical Laboratory Geneticist’ was founded from
the aforementioned subcommittee (https://www.eshg.org/668.0.html).
The major work of this committee between 2011 and 2012 (Thomas
Liehr (chair), Isabel M. Carreira (co-chair), et al.) was to introduce an
ErCLG curriculum. A proposal for a core curriculum was established in
2012 and has been slightly revised twice since then (https://www.eshg.
org/fileadmin/eshg/EBMG/CLG/Core-Curriculum_2016.pdf). The core
curriculum has been approved by the ESHG Executive Committee
Board and has additionally received support from 14 country
representatives, representing 204/345 (59%) of the EU weighted
(qualified majority) votes (https://www.eshg.org/668.0.html).
The next task in 2012 was to contact 150 individuals working as
Clinical Laboratory Geneticist (CLGs) in 44 countries. They were
requested to help aligning the requirements of the ErCLG core
curriculum (https://www.eshg.org/fileadmin/eshg/EBMG/CLG/Core-
Curriculum_2016.pdf) with those of their national guidelines for
professional education. Information was returned by colleagues from
41 countries. The results led to the allocation of these countries into
three different groups, those with a national CLG title (groups 1 and 2)
and those without (group 3) (Figure 1). Group 1 countries have national
CLG education schemes that fit to the core curriculum
by 46 of 52 points as shown in Supplementary Table 1; all
countries with national titles but falling below this cutoff are put in
group 2, and applicants must fulfill some country-specific additional
prerequisites to be eligible for the ErCLG title. Forty-four European and
four non-European countries were included in this grouping (Table 1).
In 2014/2015 the registration process for professionals to attain the
ErCLG title was opened for the first time. Only applicants from group
1 countries were eligible to apply in that year. However, 1 year later (in
the 2015/2016 call) applicants from all three groups, that is, all
European countries were able to apply for the ErCLG title.
Figure 1 Map of Europe indicating the distribution of countries with national
CLG title (groups 1 and 2) and such without (group 3).
Table 1 European country group list in alphabetic order. In case a
country is not listed yet or some changes are made in a country,
please contact EBMG-ErCLG board







Belgium 1 Medical Genetic Laboratory Supervisor




Czech Republic 1 Clinical Bioanalytician in Clinical Genetics
Denmark 1 Klinisk laboratoriegenetiker (Clinical Laboratory
Geneticist)
Estonia 3 n.a.
Finland 1 sairaalageneetikko= sjukhusgenetiker (Hospital
geneticist)





Hungary 1 Molecular Genetic Diagnostics (MD)/
Molecular Biology Diagnostics (PhD)
Iceland 3 n.a.
Ireland 3 n.a.
Israel 1 Hum. cytogeneticist, hum. molecular/biochemical
geneticist
Italy 1 Genetica Medica, Genetica Applicata, Citogen-
etica Umana, Applicazioni Biotecnologice
Latvia 2b Geneticist – medical support person
Lithuania 1 Medical geneticist (laboratory)




Netherlands 1 Clinical Laboratory Geneticist
Norway 3 n.a.
Poland 1 Laboratory Medical Genetics




Slovakia 1 Laboratory and diagnostic methods in Clinical
Genetics
Slovenia 1 Medical Genetic Laboratory Programme
Spain 3 n.a.
Sweden 1 sairaalageneetikko= sjukhusgenetiker
(Hospital geneticist)
Switzerland 1 Specialist for genetic laboratory medicine FAMH
Turkey 3 n.a.
UK 2a Healthcare Scientist Training Programme
Ukraine 3 n.a.
Non-European countries
Canada 1 Clinical Cytogenetics, Clinical Molecular Genetics
and/or Clinical Biochemical Genetics title accre-
dited by the Canadian Board of Medical Genetics
Hong Kong 3 n.a.
Saudi Arabia 3 n.a.
USA 1 Clinical Cytogenetics, Clinical Molecular Genetics
and/or Clinical Biochemical Genetics title accre-
dited by the American Board of Medical Genetics
Special requirements for group 1, 2a, 2b and 3 countries can be found at https://www.eshg.org/
587.0.html.
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The overpowering response to the first two calls was that at present
almost 300 individuals from 19 countries are holders of an ErCLG
title, which is valid for five years, before renewal is required. In the
2016/2017 call 480 further individuals applied for the title. The
possibility for recognition of professionals working in Human
Genetics diagnostic laboratories to be recognized as ‘affiliated ErCLG’
from countries outside of Europe was opened in this recent call.
Overall, all our actions aim to get a EU-recognition, based on
approved EU Directive 2005/36/EC – policy developments (https://
www.eshg.org/fileadmin/eshg/EBMG/CLG/Direttiva_36_EN.pdf) and
Proposal for modernizing the Professional Qualifications Directive=
EU Directive 2013/55/EU (https://www.eshg.org/fileadmin/eshg/
EBMG/CLG/Direttiva_55_EN.pdf). The latter has been implemented
by 16th January 2016. To be achieved nine EU countries need to have
their national CLG-title accepted as a registered profession by their
national parliaments. This is only the case for Hungary (http://net.
jogtar.hu/jr/gen/hjegy_doc.cgi?docid=A1200022.EMM) and Slovenia
(https://www.uradni-list.si/1/content?id= 103432), at present.
THE ERCLG TITLE
The ‘Clinical Laboratory Geneticists Professional Branch Board,
European Board of Medical Genetics’ offers the possibility for
recognition of professionals working in human genetics diagnostics
laboratories to be recognized as ErCLG.
From the professional point of view, and in order to provide best
possible patient care, individuals working in human genetics diag-
nostics laboratories should master the following core competencies:
(i) understanding and correct interpretation of basic mechanisms in
human genetics,
(ii) having knowledge of the patterns and modes of inheritance,
(iii) having a basic knowledge of genetically inherited disorders
including, for example, metabolic disorders,
(iv) having a comprehensive knowledge of common international
genetic nomenclature systems,
(v) having completely independency in the use of basic as well as
molecular cytogenetic techniques, to provide a best possible
diagnostic results in their own work field,
(vi) being familiar with medical ethical issues in diagnostics and
research in general and according to state laws, and
(vii) having basic knowledge about genetic tests including risks and
limitations.
During their work all applicants are obliged to follow the ‘Code of
professional practice for clinical laboratory geneticists in Europe’
(https://www.eshg.org/fileadmin/eshg/EBMG/CLG/EBMG_Code_of_-
professional_practice_2015.pdf).
To reflect that the field of human laboratory genetics is diverse, five
different areas of specializations were defined; however, there is no
difference in competence levels between the five ErCLG titles, they
simply indicate in which field the holder of the title has core
competences. (In case, eg, an ‘ErCLG with focus on Tumorgenetics’
changed during the last 3 years the field and does now do only pre-
and postnatal diagnostics he/ she may go for recertification for an
‘ErCLG focus on Clinical Genetics’ title.) The five titles are the
following:
1. General: This title confirms expertise in cytogenetics and molecular
genetics (ie, prenatal, postnatal and molecular genetics, or tumor-
cytogenetics and molecular genetics in oncology – knowledge on
Biochemical Genetics is optional). The title confirms knowledge of
how to organize/establish and lead a cytogenetic and molecular
genetic laboratory.
2. Clinical Genetics: This title confirms expertise in cytogenetics and/or
molecular genetics in prenatal and or postnatal settings. The title
confirms knowledge of how to organize/establish and lead a
cytogenetic and/or molecular genetics/cytogenetic laboratory.










signed report/year Ongoing education/Additional requirements
1 Yes MSc and/or PhD 5a years 2000 35 h per year (15 h internal and 20 h external)b
2a
2b 35 h per year (15 h internal and 20 h external)b
At least one specialized course in human genetic diagnostics with a certificate proofing
successful passing of a final test or daily tests and duration of the course of at least
3 daysc
3 Not applicable 8d years At least one specialized course in human genetic diagnostics with a certificate proofing
successful passing of a final test or daily tests and a duration of the course of at least
3 daysc
At least one specialized course in human genetic diagnostics with a certificate proofing
participation and a duration of the course of at least 3 daysc
Examination by the EBMG Professional Branch Board for Clinical Laboratory Geneticists
that includes written exam to test theoretical knowledge and individual oral discussion
checking experience in diagnosticsc
aIf working for more than 7 years reports should be signed during at least three of the last 5 years.
bRecorded for the last 2 years before application.
cSee https://www.eshg.org/fileadmin/eshg/EBMG/CLG/EBMG_Code_of_professional_practice_2015.pdf.
dIf working for more than 10 years reports should be signed during at least three of the last 5 years.
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3. Molecular Genetics: This title confirms expertise in molecular
genetics in prenatal and/or postnatal diagnostics; tumorgenetics
may be included. The title confirms knowledge of how to organize/
establish and lead a molecular genetic laboratory.
4. Biochemical Genetics: This title confirms expertise in biochemical
genetics as applied eg in metabolic disorders or mitochondriopa-
thies. The title confirms knowledge on how to organize/establish
and lead a laboratory specialized in biochemical genetics.
5. Tumor Genetics: This title confirms expertise in cytogenetics and/or
molecular genetics in oncological field. The title confirms knowl-
edge of how to organize/establish and lead a cytogenetic and
molecular genetics/cytogenetic laboratory.
The set of core competence stated above applies to all ErCLG
subtypes. The registration process is based on availability of individual
national titles/national certification system (via specialization or national
society). As every country has different education schemes and/or
different national society curriculum, the prerequisites for registration
are based on the core curriculum of the ErCLG (https://www.eshg.org/
fileadmin/eshg/EBMG/CLG/Core-Curriculum_2016.pdf).
REGISTRATION PROCESS
The registration process includes a two-step online submission
procedure: first, the applicant has to submit information on his/her
CV and upload certificates (Table 2) for the first round of evaluation.
If an applicant does not fulfill the necessary criteria, he or she is
informed about the reasons and there is no fee to pay. Up to now
more than 95% of applicants passed round 1 and were then asked to
submit additional papers and pay a registration fee. Witnesses are
invited to submit supporting letters which confirm the disclosures
applicant made about his or her own diagnostic activities.
Figure 3 (a) Distribution of holders of ErCLG title by country. (b) Distribution of gender among holders of ErCLG title. (c) Distribution of MSc and PhD among
holders of ErCLG title. (d) Age distribution of holders of ErCLG title.
Figure 2 A detailed schema of ErCLG registration process. Before applying
determine which group your country belongs to and check entering criteria
and requirements for specific country. Not requested or evaluated are
scientific records, like publication lists.
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A second evaluation round is then undertaken by the CLG branch
board members. A detailed description of the registration process is
presented in Figure 2 and can be found elsewhere.7 Finally an ErCLG
certificate that is valid for 5 years is issued.
Since the 2016/2017 call also non-European residents can apply for
an ‘affiliated ErCLG’ title. If the country of origin of a potential
applicant is not listed (Table 1) the interested person is invited to
contact the chair of the Clinical Laboratory Geneticists Professional
Branch Board, European Board of Medical Genetics for a discussion
about an application.
It may be important to add that each ErCLG has to pass at least once
a kind of examination in front of a board of colleagues. In group 1 and
2 countries such an exam is obligatory to receive the corresponding
national CLG title. Thus for candidates from group 3 countries such an
exam is part of the ErCLG scheme. Besides, no other tests or
centralized exams for ErCLG applicants are foreseen yet be the EBMG.
REACCREDITATION
The recognition as an ErCLG is valid for a 5-year period. If afterwards
the recognition is for the same or another ErCLG subtype, applicants
present documents confirming that they are still working in the same
field or accordingly have changed it. They must also demonstrate that
they are involved in signing reports, they have ongoing education
(~35 h per year) and they can present the previous ErCLG registration.
SOME STATISTICS
The ErCLG certification has enabled us to collect data on the
professionals working in human genetics diagnostics laboratories
throughout Europe. The corresponding data, based on 294 holders
of ErCLG title, are summarized in Figure 3.
Most holders of ErCLG title come from the Netherlands, followed by
Germany, Portugal, Belgium, Switzerland and Austria (Figure 3a). This
may reflect in parts the fact that members of the Clinical Laboratory
Geneticists Professional Branch Board come from these countries; thus,
better advertising in other countries could help to promote the title.
Not surprisingly there are around twice as many females than males
registered as an ErCLG; it is a well-known fact to all people working in
genetic diagnostics that women are much more represented in the
laboratories than men (Figure 3b). Furthermore, a PhD title seems to
be expected from most practitioners working in Human Genetics
diagnostic laboratories; 80% of all ErCLG holders have a PhD
(Figure 3c). Interestingly, as yet the ErCLG-title has attracted mainly
specialists at the age of 445 years of age. Only ~ 30% of the
certificated specialists were below 44 years (Figure 3d).
Concerning the distribution of approved ErCLG subtitles: the
general title was given to 66% of applicants, the molecular genetic
one to 23% and the clinical genetic title to 6%. The titles ErCLG
(focus on tumor genetics) and ErCLG (focus on biochemical genetics)
were only requested in 4% and 1% of the applications, respectively.
THE FUTURE
The ErCLG registration process is a unique chance to recognize and
strengthen the status of (non-medical) specialists working in human
genetic diagnostics in Europe and worldwide. ErCLGs may in future
be important as well in laboratory developed tests and innovation via
cowork with commercial companies. Through registration we get a
feeling for and a representation of the absolute numbers we represent
in this important medical field. Thus, it is important to encourage as
many as possible non-registered colleagues to join us. For people
coming from countries with national certificate it is easier than for
those without national title. For the latter courses are offered (https://
www.eshg.org/669.0.html): these are not meant to replace a national
education system, but to augment the national training and can be
used to enable applicants to acquire and/or demonstrate the compe-
tences that future ErCLG registrants will have.
Attaining EU-recognition as a profession for European CLGs is a
major goal for the future. Each Human Genetic society in EU member
states is herewith called to think about steps to bring their national
parliaments towards formally accepting their national CLG-titles.
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